UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept.
by Lee Han-soo
2018-10-11 16:31
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
by Lee Han-soo
2018-10-11 12:10
‘Korea publishes many biotech papers but rarely links them to biz’
by Nam Doo-hyun
2018-10-10 16:35
GC opens new cell research center
by Lee Han-soo
2018-10-10 11:45
More biotech stocks come in top 20 on KOSDAQ
by Nam Doo-hyun
2018-10-10 11:20
라인
Newly listed biotech firms perform poorly on KOSDAQ
by Nam Doo-hyun
2018-10-04 13:09
‘Samsung C&T’s value to rise on BioLogics’ increased value’
by Nam Doo-hyun
2018-10-03 10:11
More doctoral degree holders wanted at biotech ventures
by Nam Doo-hyun
2018-10-02 14:40
FDA to review Samsung Bioepis’ application for anti-arthritis biosimilar
by Lee Han-soo
2018-09-27 11:22
Biois registers patent to develop TNF-alpha inhibitor
by So Jae-hyeon
2018-09-20 16:45
라인
Celltrion, Emory University to develop new drug for Atherosclerosis
by Lee Han-soo
2018-09-20 13:22
FDA approves Bifido’s strain as new dietary ingredient
by Lee Han-soo
2018-09-18 17:14
Nature Cell shares spike despite investment alert warning
by Nam Doo-hyun
2018-09-14 16:08
GC Cell shares spike on winning FDA nod for Immuncell-LC
by Nam Doo-hyun
2018-09-12 16:05
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
by So Jae-hyeon
2018-09-12 14:25
라인
‘ToolGen’s KOSDAQ listing might be in peril’
by Nam Doo-hyun
2018-09-10 14:59
‘Pharmaceutical stocks to bottom out soon’
by Nam Doo-hyun
2018-08-29 14:34
Celltrion completes P3 clinical trials for Remsima in Europe
by Lee Han-soo
2018-08-29 14:33
Merck to globally distribute T&R Biofab’s bio-ink
by Lee Han-soo
2018-08-22 12:30
Biotech firms grudge over regulator’s plan to toughen disclosure rules
by So Jae-hyeon
2018-08-17 11:51
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top